Sandboxaq has received a $25 million research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) LRRK2 Investigative Therapeutics Exchange (LITE) program to advance drug candidates for Parkinson's disease (PD).

Biopharmas raising money in public or private financings, including: Eli Lilly, Kivu, Proqr.

Med-tech firms raising money in public or private financings, including: Onward Medical, Sonavex.

Kivu Bioscience has closed a $92 million series A financing to advance its topoisomerase I inhibitor-based antibody-drug conjugate (ADC) pipeline into the clinic.

Biopharmas raising money in public or private financings, including: Agomab, Engene, Molecular Partners, Mustang, Oaktree Acquisition, Septerna, Tela.

Med-tech firms raising money in public or private financings, including: Vensica.

Biopharmas raising money in public or private financings, including: Biovie, Epitopea, Medivir, Starget.